Publications by authors named "E Maranzano"
Aims: The National Palliative Care and Interventional Radiotherapy Study Groups of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) carried out a survey whose aim was to obtain a "snapshot" of the real-world practice of nonmelanoma skin cancer (NMSC) treatments in Italy.
Materials And Methods: The survey was conducted on SurveyMonkey's online interface and was sent via e-mail to our society Radiation Oncologists.
Results: Fifty-eight Italian radiation oncologists (ROs), representing 54 centers, answered the survey.
• Nausea and vomiting are considered amongst the most troublesome adverse events for patients receiving antineoplastics. • The guideline covers emetic risk classification, prevention and management of treatment-induced nausea and vomiting. • The Consensus Committee consisted of 34 multidisciplinary, health care professionals and three patient advocates.
View Article and Find Full Text PDFArticle Synopsis
- The manuscript aims to update guidelines for managing nausea and vomiting caused by radiotherapy and chemoradiotherapy (RINV and C-RINV) by reviewing recent literature to improve antiemetic treatment options.
- A systematic review identified 20 relevant articles, with only one study influencing new clinical recommendations, specifically in changing advice for "low emetic risk."
- The updated guidelines maintain serotonin receptor antagonists as essential for managing high to moderate risks while suggesting that antiemetic prophylaxis is not needed for the "low emetic risk" category to prevent overtreatment.
Introduction: Bones are frequent sites of metastatic disease, observed in 30-75% of advanced cancer patients. Quality of life (QoL) is an important endpoint in studies evaluating the treatments of bone metastases (BM), and many patient-reported outcome tools are available. The primary objective of this systematic review was to compile a list of QoL issues relevant to BM and its interventions.
View Article and Find Full Text PDF